Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenue
Orthopedic product sales	$ 15,277	$ 14,942	$ 28,227	$ 27,451
Other revenue		33	9	66
Total Revenue	15,277	14,975	28,236	27,517
Cost of sales	6,903	5,460	12,302	9,911
Gross Profit	8,374	9,515	15,934	17,606
Operating Expenses
General and administrative	3,797	4,173	7,766	7,200
Sales and marketing	5,636	5,590	10,845	10,445
Research and development	241	243	454	458
Total Operating Expenses	9,674	10,006	19,065	18,103
Loss from Operations	(1,300)	(491)	(3,131)	(497)
Other Expense
Interest expense	(397)	(199)	(757)	(201)
Total Other Expense	(397)	(199)	(757)	(201)
Net Loss Before Provision for Income Taxes	(1,697)	(690)	(3,888)	(698)
Provision for Income Taxes Current and Deferred	(13)	(43)	(35)	(64)
Net Loss	$ (1,710)	$ (733)	$ (3,923)	$ (762)
Net Loss Per Share:
Basic	$ (0.02)	$ (0.01)	$ (0.04)	$ (0.01)
Dilutive	$ (0.02)	$ (0.01)	$ (0.04)	$ (0.01)
Shares used in the computation:
Basic	87,313,701	86,707,286	87,252,521	83,993,159
Dilutive	87,313,701	86,707,286	87,252,521	83,993,159